This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September quarter revenue rises 175% on restated base; profit after tax Rs 149.52 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended September 30, 2026: revenue from operations was Rs 4,754.83 lakh versus Rs 1,728.09 lakh a year earlier, up 175.1%; profit after tax was Rs 149.52 lakh versus a loss of Rs 1,428.08 lakh. Six-month standalone revenue was Rs 10,353.42 lakh and profit after tax Rs 823.07 lakh, versus restated Rs 2,955.30 lakh and a loss of Rs 3,132.21 lakh. Prior figures were restated after associate ITIL merged, affecting comparability.
Strong revenue growth supports sentiment, but merger-related uncertainty and a small Rs 149.52 lakh quarterly profit may cap the stock impact.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹47.55 Cr | ₹0.00 Cr | turned positive |
| Operating profit | −₹1.51 Cr | −₹0.25 Cr | loss widened |
| Profit after tax | ₹1.50 Cr | −₹0.47 Cr | turned positive |
| EBITDA margin | 3.5% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.